Logo

Genetix Closes Acquisition of Applied Imaging

Mar 07, 2007
NEW YORK (GenomeWeb News) — Genetix last week said it has completed its acquisition of Applied Imaging.
 
Genetix plans to use the company’s protein biomarker hardware and software with its own ClonePix and CloneSelect Imager and reagents to “track the progress of drug discovery” from lab to clinic.
 
Applied Imaging’s Ariol instruments and CytoVision software are used to study tumors at the protein biomarker level to find targets, monitor responses, and predict the how a drug will work.
 
Genetix said last September it would acquire Applied Imaging for $18.3 million in cash.

Breaking News
The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.